Report - HBM Healthcare Investments Ltd · Biotech Pharma. x 3.1. 0 50 100 150 200 250 Biotech Pharma. x 0.5. Source: HBM Biopharma Drug Approval Report, 2018 Source: EY Biotechnology Report

Please pass captcha verification before submit form